9 of 100

Book your treatment review

Guideline advice, not formally gradedADHD evidence

Regular reviews match your care to current needs, benefits and side effects.

Start with the time you have

1 minute

Start a note called 'treatment review' and put the first thing you want to raise in it.

Recommended by ADHD clinical guidelines, but nobody has pooled the trials and graded how sure they are.
Guideline advice is a considered judgement, not a measured certainty.
Measured in people with ADHD.

NICE NG87 1.10.1 annual review recommendation; a care standard, not a rated treatment-effect estimate.

at most 1 year maximum routine interval between full medication reviewsNICE NG87 recommendation 1.10.1 NICE, Attention deficit hyperactivity disorder: diagnosis and management (NG87), recommendations

ADHD treatment needs can change as school, work, health and responsibilities change.
NICE recommends a medication review at least once a year, covering how well treatment works through the day, adverse effects, preferences and whether treatment is still needed; the NHS describes yearly check-ups.
This is a minimum interval, not a reason to postpone help when treatment is causing problems.

Check when your last full medication review was and who is responsible for the next one.
Bring a short account of what treatment helps with and what is still hard.
Discuss new health conditions, life changes and any unwanted effects.
Ask for a written plan identifying follow-up, monitoring and who will prescribe.

Bring changes in work demands or school support that change what you want from treatment.
Ask who will handle prescriptions and physical checks after the review.

Common mistakeA prescription renewal is not necessarily a full review. Ask what was actually assessed.
Common mistakeA yearly review does not replace earlier monitoring, or getting help with new side effects.

Evidence grade: A Moderate or high certainty evidence in people with ADHD, or an explicit ADHD guideline recommendation.
The number: At least 1 ADHD medication review each year (NICE, 2019)
Benefit: 79/100 An editorial priority for the general list, weighted by certainty. It does not predict what will happen for you.
Effort: Quick win

I already do this Back to the hundred

General information about ADHD, not a diagnosis or an individual treatment plan.
Tailoring changes the order of suggestions; it does not assess you.
Medication decisions belong with you and a qualified clinician.